Granules India gets EU GMP certificate for Unit V facility in Andhra Pradesh

30 Jan 2025 Evaluate

Granules India has received EU GMP certificate for Active Pharmaceutical Ingredients (APIs) and Finished Dosages (FDs) for its Unit V facility located at Visakhapatnam, Andhra Pradesh. The EU (National Centre for Public Health and Pharmacy, Hungary) Authority conducted the audit of the facility in the month of November 2024. This facility manufactures APIs & formulations of oncology and non-oncology products.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages.


Granules India Share Price

567.00 30.15 (5.62%)
22-Jan-2026 13:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.80
Dr. Reddys Lab 1222.15
Cipla 1375.80
Zydus Lifesciences 884.80
Lupin 2171.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×